References
Adlercreutz, H. and Tenhunen, R.: Some aspects of the interaction between natural and synthetic female sex hormones and the liver. American Journal of Medicine 49: 630 (1970).
Alvares, A.P.; Schilling, Gayle, and Levin, W.: Species differences in the induction of microsomal hemoproteins and 3,4-benzpyrene hydroxylase by phenobarbital and 3-methylcholanthrene. Journal of Pharmacology and Experimental Therapeutics 175: 4 (1970).
Alvares, A.P.; Schilling, Gayle; Levin, W.; Kuntzman, R.; Brand, L., and Mark, L.C.: Cytochromes P-450 and b5 in human liver microsomes. Clinical Pharmacology and Therapeutics 10: 655 (1969).
Arias, I.M.; Gartner, L.M.; Cohen, M.; Ben Ezzer, Judith, and Levi, A.J.: Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. American Journal of Medicine 47: 395 (1969).
Arias, I.M.; Gartner, L.; Furman, M., and Wolfson, S.: Studies of effect of several drugs on hepatic glucuronide formation in newborn rats and humans. New York Academy of Sciences 111: 274 (1963).
Atkinson, R.M.; and Ditman, R.S.: Tranylcypromine: A review. Clinical Pharmacology and Therapeutics 6: 631 (1965).
Berk, P.D.; Bloomer, J.R., and Berlin, N.L.: Y and Z: New terms in the bilirubin equation. New England Journal of Medicine 283: 1166 (1970).
Black, M. and Billing, Barbara H.: Hepatic bilirubin UDP-glucuronyl transferase activity in liver disease and Gilbert’s syndrome. New England Journal of Medicine 280: 1266 (1969).
Black, M. and Sherlock, Sheila.: Treatment of Gilbert’s syndrome with phenobarbitone. Lancet 1: 1359 (1970).
Brodie, B.B.: Physiochemical and biochemical aspects of pharmacology. Journal of the American Medical Association 202: 600 (1967).
Brodie, B.B.; Burns, J.J., and Weiner, M.: Medicina experimentalis (Basel) 1: 290 (1959).
Brodie, B.B.; Gillette, J.R., and La Du, B.N.: Enzymatic metabolism of drugs and other foreign compounds. Annual Review of Biochemistry 27: 427–454 (1958).
Brown, R.R.; Miller, J.A., and Miller, E.C.: The metabolism of methylated aminoazo dyes IV. Dietary factors enhancing demethylation in vitro. Journal of Biological Chemistry 209: 211 (1954).
Busfield, D.; Child, K.J.; Atkinson, R.M., and Tomich, E.G.: An effect of phenobarbitone on blood levels of griseofulvin in man. Lancet 2: 1042 (1963).
Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews 19: 317 (1967).
Conney, A.H.; Davison, D.; Gastel, R., and Burns, J.J.: Adaptive increases in drug-metabolising enzymes induced by phenobarbital and other drugs. Journal of Pharmacology and Experimental Therapeutics 130: 1–8 (1960).
Cook, G.C.; Mulligan, Rosemary, and Sherlock, Sheila.: Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quarterly Journal of Medicine 40: 159 (1971).
Cooksley, W.G.E. and Powell, L.W.: Unpublished data (1971).
Cucinell, S.A.; Conney, A.H.; Sansur, M., and Burns, J.J.: Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicumarol) and diphenylhydantoin (Dilantin). Clinical Pharmacology and Therapeutics 6: 420 (1965).
Davies, D.S.; Gigon, P.L., and Gillette, J.R.: Species and sex differences in electron transport systems in liver microsomes and their relationship to ethylmorphine demethylation. Life Sciences 8: 85 (1969).
Di Augustine, R.P.; and Fouts, J.R.: The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome. Biochemical Journal 775: 547 (1969).
Editorial British Medical Journal 2: 586 (1964).
Eling, T.E.; Harbison, R.D.; Becker, B.A., and Fouts, J.R.: Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism. Journal of Pharmacology and Experimental Therapeutics 171: 127 (1970).
Emans, J.B. and Jones, A.L.: Hypertrophy of liver cell smooth surfaced reticulum following progesterone administration. Journal of Histochemistry and Cytochemistry 16: 561 (1968).
Ernster, L. and Orrenius, S.: Substrate-induced synthesis of the hydroxylating enzyme system of liver microsomes. Federation Proceedings 24: 1190 (1965).
Estabrook, R.W.; Franklin, M.R.; Dohen, Beverley; Shigamatzu, A., and Hildebrandt, A.G.: Influence of hepatic microsomal mixed function oxidation reactions on cellular metabolic control. Metabolism 20: 187 (1971).
Fleischner, G. and Arias, I.M.: Recent advances in bilirubin formation, transport, metabolism and excretion. American Journal of Medicine 49: 576 (1970).
Fouts, J.R.: Factors influencing the metabolism of drugs in liver microsomes. Annals of the New York Academy of Sciences 104: 875 (1963).
Fouts, J.R.: The stimulation and inhibition of hepatic microsomal drug-metabolizing enzymes with special reference to effects of environmental contaminants. Toxicology and Applied Pharmacology 17: 804 (1970).
Fujii, K.; Jaffe, H.; Bishop, Yvonne Arnold; Elsie Mackintosh, D.; and Epstein, S.S.: Structure activity relations for methylenedioxyphenyl and related compounds on hepatic microsomal enzyme function, as measured by prolongation of hexobarbital narcosis and zoxazolamine paralysis in mice. Toxicology and Applied Pharmacology 16: 482 (1970).
Garner, R.C. and McLean, A.E.M.: Increased susceptibility to carbon tetrachloride poisoning in the rat after pretreatment with oral phenobarbitone. Biochemical Pharmacology 18: 645 (1969).
Gartner, L.M. and Arias, I.M.: Formation, transport, metabolism and excretion of bilirubin. New England Journal of Medicine 280: 1339 (1969).
Gigon, PL.; Gram, T.E., and Gillette, J.R.: Studies on the rate of reduction of hepatic microsomal cytochrome P450 by reduced nicotinamide adenine dinucleotide phosphate: Effect of drug substrates. Molecular Pharmacology 5: 109 (1969).
Gillette J.R.: Aspects of drug metabolism relating to pharmacologic activity. American Journal of Pharmacy 147: 64–75 (1969).
Goss, J.E. and Dickhaus, D.W.: Increased bishydroxycoumarin requirements in patients receiving phenobarbital. New England Journal of Medicine 273: 1094 (1965).
Govier, W.C.: Reticuloendothelial cells as the site of sulfanilamide acetylation in the rabbit. Journal of Pharmacology and Experimental Therapeutics 150: 305 (1965).
Granick, S.: The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: A response to certain drugs, sex hormones, and foreign chemicals. Journal of Biological Chemistry 241: 1359 (1966).
Granick, S. and Kappas, A.J.: Steroid induction of porphyrin synthesis in liver cell culture. I. Structural basis and possible physiological role in the control of heme formation. Journal of Biological Chemistry 242: 4587 (1967).
Greim, H. and Remmer, H.: Abbauhemmung und Synthesesteigerung bei der Vermehrung mikrosomaler Cytochrome durch Phenobarbital. Naunyn-Schmiedebergs Archiv für Pharmakologie 264: 238 (1969).
Gumbmann, M.R. and Williams, S.N.: Effect of phenobarbital pretreatment on the ability of aflatoxin B1 to inhibit ribonucleic acid synthesis in rat liver. Biochemical Pharmacology 19: 2861 (1970).
Hammer, W.; Martens, S., and Sjöqvist, F.: A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man. Clinical Pharmacology and Therapeutics 10: 44 (1969).
Hart, L.G.; Adamson, R.H.; Morris, H.P., and Fouts, J.R.: The stimulation of drug metabolism in various rat hepatomas. Journal of Pharmacology and Experimental Therapeutics 149: 7 (1965).
Hildebrandt, A.; Remmer, H., and Estabrook, R.W.: Cytochrome P450 of liver microsomes — one pigment or many. Biochemical and Biophysical Research Communications 30: 607 (1968).
Holtzman, J.L. and Gillette, J.R.: The effect of phenobarbital on the synthesis of microsomal phospholipid in female and male rats. Biochemical and Biophysical Research Communications 22: 639–643 (1966).
Holtzman, J.L.; Gram, T.E.; Gigon, R.L., and Gillette, J.R.: The distribution of the components of mixed-function oxidase between the rough and the smooth endoplasmic reticulum of liver cells. Biochemical Journal 770: 407 (1968).
Hunter, J.; Maxwell, J.D.; Carrella, M.; Stewart, D.A., and Williams, R.: Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man. Lancet 1: 572 (1971).
Jones, A.L.; Marver, H.S., and Kroe, E.M.: Anatomical Record 166: 326 (1970).
Jondorf, W.R.; Simon, D.C., and Aunimelech, M.: The stimulation of amino acid incorporation in a mammalian system with phenobarbital, 3-methylcholanthrene and cycloheximide. Biochemical and Biophysical Research Communications 22: 644 (1966).
Judah, J.D.; McLean, A.E.M., and McLean, Elizabeth K: Biochemical mechanisms of liver injury. American Journal of Medicine 49: 609 (1970).
Kappas, A. and Granick, S.: Steroid induction of porphyrin synthesis in liver cell culture. II. The effects of heme, uridine diphosphate glucuronic acid, and inhibitors of nucleic acid and protein synthesis on the induction process. Journal of Biological Chemistry 243: 346 (1968).
Kappas, A. and Song, C.S.: Enzyme induction in the liver. Gastroenterology 55: 731 (1968).
Kater, R.M.H.; Roggin, G; Tobon, F.; Zieve, P., and Iber, F.L.: Increased rate of clearance of drugs from the circulation of alcoholics. American Journal of Medical Sciences 258: 35 (1969).
Kato, R. and Chiesara, E.: Increase of pentobarbitone metabolism induced in rats pretreated with some centrally acting compounds. British Journal of Pharmacology and Chemotherapy 18: 29–38 (1962).
Kato, R.; Loeb, L., and Gelboin, H.V.: Increased sensitivity of microsomes from phenobarbital-treated rats to synthetic messenger RNA (polyuridylic acid): lack of effect on ribosomes. Nature (Lond.) 205: 668 (1965).
Kato, R. and Vassanelli, P.: Induction of increased meprobamate metabolism in rats pretreated with some neurotropic drugs. Biochemical Pharmacology 11: 779–794 (1962).
Kinoshita, Florence K. and DuBois, K.P.: Induction of hepatic microsomal enzymes by herban, diuron, and other substituted urea herbicides. Toxicology and Applied Pharmacology 17: 406 (1970).
Koudstaal, J. and Hardonk, M.J.: Histochemical demonstration of enzymes related to NADPH-dependent hydroxylating systems in rat liver after phenobarbital treatment. Histochemie 20: 68 (1969).
Kristensen, M.; Hansen, J.M., and Skovsted, L.: The influence of phenobarbital on the half-life of diphenyl-hydantoin in man. Acta Medica Scandinavica 185: 347 (1969).
Kröber, F.; Lance, G; Mathes, S., and Mor, G.: Qualitative Änderungen in Lebermikrosomen phenobarbital-behandelter Kaninchen. Änderungen der spektralen Dissoziations-Konstanten (Ks) von Anilin und N-Athylaninin, der scheinbaren Michaelis-Konstanten (Km) für die Hydroxylierung dieser Substrate und der Affinität der beteiligten Enzyme für Sauerstoff und Kohlenmonoxid. Naunyn-Schmiedebergs Archiv für Pharmakologie 267: 307 (1970).
Kuntzman, R.; Laurence, D., and Conney, A.H.: Michaelis constants for the hydroxylation of the steroid hormones and drugs by rat liver microsomes. Molecular Pharmacology 1: 163 (1965).
Laidlaw, J.; Read, A.E., and Sherlock, J.: Morphine tolerance in hepatic cirrhosis. Gastroenterology 40: 389 (1961).
Levi, A.J.; Sherlock, Sheila, and Walker, D.: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1: 1275 (1968).
Lombrozo, L. and Mitoma, C: Effect of caffeine on hepatic microsomal cytochrome P450. Biochemical Pharmacology 19: 2317 (1970).
Louis-Ferdinand, R.T. and Fuller, G.C.: Suppression of hepatic ribonuclease during phenobarbital stimulation of drug metabolism. Biochemical and Biophysical Research Communications 38: 811 (1970).
McLean, Elizabeth K.; McLean, A.E.M., and Sutton, P.M.: Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. British Journal of Experimental Pathology 50: 502 (1969).
Mackay, I.R.: Chromic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine and prednisolone. Quarterly Journal of Medicine 37: 379 (1969).
Madhaven, T.V.; Tulbule, P.G., and Gopalan, C.: Aflatoxin-induced hepatic fib rosis in rhesus monkeys. Archives of Pathology (Chicago) 79: 466 (1965).
Mannering, G.J.: Properties of cytochrome P450 as affected by environmental factors: Qualitative changes due to administration of polycyclic hydrocarbons. Metabolism 20: 228 (1971).
Maurer, H.M.; Wolff, J.A.; Finster, M.; Poppers, P.J.; Pantuck, E.; Kuntzman, R., and Conney, A.H.: Reduction in concentration of total serum-bilirubin in offspring of women treated with phenobarbitone during pregnancy. Lancet 2: 122 (1968).
Mistilis, S.P. and Garske, Angela.: Induction of alcohol dehydrogenase in liver and gastrointestinal tract. Australasian Annals of Medicine 18: 227 (1969).
Mulder, G.J.: The effect of phenobarbital on the sub-microsomal distribution of uridine disphosphate glucuronyl transferase from rat liver. Biochemical Journal 117: 319 (1970).
Neale, M.G. and Parke, D.V.: The effect of pregnancy on the hydroxylation and reduction of drugs and cytochrome P450 content of rat liver microsomes. Biochemical Journal 113: 12 (1969).
Neuvonen, P.J.; Gothoni, G.; Hackman, R., and Björksten, K.P.: Interference of iron with the absorption of tetracyclines in men. British Medical Journal 4: 532 (1970).
Omura, T. and Sato, R.: The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 239: 2370 (1964).
Omura, T.; Sato, R.; Cooper, D.Y.; Rosenthal, O., and Estabrook, R.W.: Function of cytochrome P450 of microsomes. Federation Proceedings 24: 1181 (1965).
Orrenius, S. and Ernster, L.: Biochemical and Biophysical Research Communications 16: 60 (1964).
Quinn, G.P.; Axelrod, J., and Brodie, B.B.: Biochemical Pharmacology 1: 152 (1958).
Remmer, H: Naturwissenschaften 45: 189 (1958).
Remmer, H.: Ciba Foundation Symposium. Enzymes and Drug Action p. 276 (1962).
Remmer, H.: Induction of drug-metabolizing enzymes in the endoplasmic reticulum of the liver by treatment with drugs. German Medical Monthly 13: 53–59 (1968).
Remmer, H.; Greim, H.; Schenkmen, J.B., and Estabrook, R.W.: Methods for the evaluation of hepatic microsomal mixed function oxidase levels and cytochrome P450. Methods in Enzymology 10: 703 (1967).
Remmer, H. and Merker, HJ.: Drug-induced changes in the liver endoplasmic reticulum: Association with drug-metabolizing enzymes. Science 142: 1657 (1963).
Roberts, P.; Turnbull, M.J., and Winterburn, A.: Diurnal variation in sensitivity to and metabolism of barbiturate in the rat: Lack of correlation between in vivo and in vitro findings. European Journal of Pharmacology 12: 375 (1970).
Rosen, F.; Raina, P.N.; Milholland, R.J., and Nichol, CA.: Induction of several adaptive enzymes by actinomycin. Science 146: 661 (1964).
Rubin, E.; Gang, H,; Misra, P.S., and Lieber, C.S.: Inhibition of drug metabolism by acute ethanol intoxication. A hepatic microsomal mechanism. American Journal of Medicine 49: 801 (1970).
Rubin, E. and Lieber, C.S.: Hepatic microsomal enzymes in man and rat: Induction and inhibition by ethanol. Science 162: 690 (1968).
Scholler, K.L.: Electron-microscopic and autoradiographic studies on the effect of halothane and chloroform on liver cells. Acta anaesthesiologica Scandinavica 32 (Suppl.): 5–62 (1968).
Schmid, R.; Marver, H.S., and Hammaker, L.: Enhanced formation of rapidly labelled bilirubin by phenobarbital: hepatic microsomal cytochromes as a possible source. Biochemical and Biophysical Research Communications 24: 319–328 (1966).
Solomon, H.M. and Schrogie, J.J.: The effect of various drugs on the binding of warfarin-14C to human albumin. Biochemical Pharmacology 16: 1219–1226 (1967).
Stiehl, A.; Admirand, W.H., and Thaler, M.M.: Effects of phenobarbital on intrahepatic and extrahepatic cholestasis. Gastroenterology 60: 183 (1971).
Thomas, J.: Drug interactions. Some basic mechanisms. II: Interactions not related to drug metabolism. New Ethicals 10 (3) 58 New Ethicals and Medical Progress 6: (3)64 (1969).
Thurman, R.G. and Scholz, R.: Mixed function oxidation in perfused rat liver. Federation Proceedings 28: 3623 (1969).
Trolle, D.: Phenobarbitone for low-birth-weight babies. Lancet 2: 1123 (1968).
Vesell, E.S. and Page, J.G.: Genetic control of drug levels in man: Phenylbutazone. Science 159: 1479 (1968).
Weiner, I.M.; Washington, J.A., and Mudge, G.H.: Studies on the renal excretion of salicylate in the dog. Bulletin of the Johns Hopkins Hospital 106: 333(1960).
Welch, R.M.; Harrison, Y.E.; Conney, A.H.; Poppers, P.J., and Finster, M.: Cigarette smoking: Stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in human placenta. Science 160: 541 (1968).
Werk, E.E.; Sholiton, L.J., and Olinger, C.P.: 2nd International Congress on Hormonal Steroids, Milan. Abstracts of the International Congress Series III p. 301 (1966).
Whelton, M.J.; Krustev, L.P., and Billing, Barbara H.: Reduction in serum bilirubin by phenobarbital in adult unconjugated hyperbilirubinaemia. Is enzyme induction responsible? American Journal of Medicine 45: 160 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cooksley, W.G.E., Powell, L.W. Drug Metabolism and Interaction with Particular Reference to the Liver. Drugs 2, 177–189 (1971). https://doi.org/10.2165/00003495-197102030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197102030-00001